Index RUT P/E - EPS (ttm) -0.24 Insider Own 68.04% Shs Outstand 174.08M Perf Week -11.73%
Market Cap 3.39B Forward P/E 34.89 EPS next Y 0.56 Insider Trans -0.32% Shs Float 55.66M Perf Month -8.02%
Income -40.60M PEG - EPS next Q 0.21 Inst Own 46.43% Short Float 16.72% Perf Quarter 4.34%
Sales 10.59B P/S 0.32 EPS this Y 143.43% Inst Trans -0.91% Short Ratio 6.39 Perf Half Y 59.10%
Book/sh 9.28 P/B 2.10 EPS next Y -1.82% ROA -0.72% Short Interest 9.31M Perf Year 86.86%
Cash/sh 0.21 P/C 94.35 EPS next 5Y - ROE -3.61% 52W Range 7.85 - 24.82 Perf YTD 14.45%
Dividend Est. - P/FCF - EPS past 5Y 10.47% ROI -0.91% 52W High -21.47% Beta 1.80
Dividend TTM - Quick Ratio 0.97 Sales past 5Y 18.23% Gross Margin 14.50% 52W Low 148.28% ATR (14) 0.95
Dividend Ex-Date - Current Ratio 1.35 EPS Y/Y TTM 80.18% Oper. Margin 3.08% RSI (14) 36.77 Volatility 3.84% 4.08%
Employees 600 Debt/Eq 1.83 Sales Y/Y TTM 25.72% Profit Margin -0.38% Recom 1.17 Target Price 24.68
Option/Short Yes / Yes LT Debt/Eq 1.75 EPS Q/Q 93.80% Payout - Rel Volume 1.51 Prev Close 20.40
Sales Surprise 6.93% EPS Surprise -28.53% Sales Q/Q 28.82% Earnings Mar 06 BMO Avg Volume 1.46M Price 19.49
SMA20 -13.19% SMA50 -1.57% SMA200 28.27% Trades
Volume 2,194,117 Change -4.46%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-12-24 Initiated CJS Securities
Market Outperform
Oct-11-24 Initiated KeyBanc Capital Markets
Sector Weight
Jun-21-24 Initiated BTIG Research
Buy
$15
Mar-06-24 Initiated HSBC Securities
Buy
$13
Feb-27-24 Upgrade Deutsche Bank
Hold → Buy
$11.50
Feb-20-24 Initiated Wells Fargo
Overweight
$15
Feb-20-24 Initiated UBS
Buy
$15
Feb-20-24 Initiated Morgan Stanley
Overweight
$18
Feb-20-24 Initiated Leerink Partners
Outperform
$15
Feb-20-24 Initiated Jefferies
Buy
$18
Feb-20-24 Initiated Guggenheim
Buy
$15
Feb-20-24 Initiated Goldman
Buy
$26
Feb-20-24 Initiated Deutsche Bank
Hold
$11.50
Feb-20-24 Initiated BofA Securities
Buy
$14
Show Previous Ratings
Feb-14-25 03:02PM
01:11PM
Feb-13-25 01:13PM
04:01AM
Feb-11-25 08:30AM
04:03AM
Loading…
04:03AM
Feb-06-25 04:05PM
Feb-02-25 04:31PM
Jan-22-25 05:36AM
02:00AM
01:07AM
(Thomson Reuters StreetEvents)
Jan-21-25 12:52PM
Jan-20-25 06:30PM
Jan-09-25 05:05PM
Jan-07-25 10:50AM
12:00PM
Loading…
Jan-02-25 12:00PM
Dec-11-24 04:05PM
Nov-26-24 05:00PM
Nov-21-24 04:05PM
Nov-06-24 04:35PM
Nov-02-24 03:01AM
Nov-01-24 06:00AM
Oct-31-24 09:04AM
Oct-12-24 05:48PM
Oct-07-24 03:03PM
Oct-01-24 04:05PM
Sep-30-24 07:30AM
Sep-14-24 02:17AM
Sep-13-24 04:00PM
Sep-12-24 11:17AM
04:30PM
Loading…
Sep-03-24 04:30PM
Aug-26-24 09:00PM
Aug-22-24 04:05PM
Aug-02-24 06:00AM
Jul-08-24 07:30AM
Jul-02-24 04:05PM
Jun-24-24 04:55PM
Jun-06-24 04:35PM
Jun-03-24 07:30AM
May-22-24 04:05PM
07:30AM
May-20-24 07:30AM
May-08-24 09:55AM
May-05-24 08:14AM
May-03-24 03:24AM
May-02-24 10:57AM
06:00AM
Apr-26-24 05:09PM
Apr-10-24 04:35PM
Apr-09-24 04:05PM
Apr-04-24 07:30AM
Mar-26-24 07:30AM
Mar-21-24 07:30AM
Mar-20-24 04:35PM
Mar-14-24 04:45PM
Mar-01-24 08:42AM
Feb-29-24 06:30AM
Feb-15-24 04:35PM
Jan-26-24 04:50PM
04:20PM
(The Wall Street Journal)
04:05PM
BrightSpring Health Services, Inc. engages in the provision of a platform of complementary health services delivering and pharmacy solutions for complex populations in home and community settings. It operates under the Pharmacy Solutions and Provider Services segments. The Pharmacy Solutions segment includes infusion and specialty pharmacy, and home and community pharmacy. The Provider Services segment is involved in home health care and community and rehab care. The company was founded in 1974 and is headquartered in Louisville, KY.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Walgreens Boots Alliance, Inc. Former 10% owner Feb 18 '25 Sale 21.16 12,000,000 253,920,000 11,239,996 Feb 20 04:30 PM Walgreen Co. 10% Owner Feb 18 '25 Proposed Sale 22.15 12,000,000 265,800,000 Feb 18 09:07 PM Walgreens Boots Alliance, Inc. 10% Owner Sep 11 '24 Sale 11.13 11,619,998 129,330,578 23,239,996 Sep 13 07:04 PM KKR Group Partnership L.P. 10% Owner Sep 11 '24 Buy 11.13 11,619,998 129,330,578 92,959,984 Sep 13 04:44 PM KKR Phoenix Aggregator L.P. 10% Owner Sep 11 '24 Buy 11.13 11,619,998 129,330,578 92,959,984 Sep 13 04:36 PM DAmbrosio Matthew Director May 20 '24 Buy 11.46 1,000 11,461 1,000 May 21 06:17 PM Yowler Jennifer President, PharMerica Mar 15 '24 Buy 8.21 3,000 24,630 60,880 Mar 18 03:27 PM Mattingly James F Jr See Remarks Mar 15 '24 Buy 8.26 6,080 50,221 134,780 Mar 18 03:27 PM ROUSSEAU JON B See Remarks Mar 15 '24 Buy 8.09 18,400 148,856 369,763 Mar 18 03:26 PM ROUSSEAU JON B See Remarks Mar 15 '24 Buy 8.09 18,400 148,856 1,025,636 Mar 18 03:26 PM Phipps Jennifer A Chief Accounting Officer Mar 14 '24 Buy 8.14 12,300 100,122 165,618 Mar 15 05:34 PM Mattingly James F Jr See Remarks Mar 14 '24 Buy 8.18 12,280 100,450 128,700 Mar 15 05:34 PM ROUSSEAU JON B See Remarks Mar 14 '24 Buy 8.12 37,405 303,729 39,352 Mar 15 05:33 PM
Index S&P 500 P/E 17.36 EPS (ttm) 3.66 Insider Own 0.15% Shs Outstand 1.26B Perf Week -4.35%
Market Cap 80.04B Forward P/E 9.23 EPS next Y 6.88 Insider Trans 1.61% Shs Float 1.26B Perf Month 19.80%
Income 4.61B PEG 1.27 EPS next Q 1.57 Inst Own 84.19% Short Float 1.70% Perf Quarter 13.26%
Sales 372.69B P/S 0.21 EPS this Y 8.67% Inst Trans 2.75% Short Ratio 1.59 Perf Half Y 7.78%
Book/sh 59.97 P/B 1.06 EPS next Y 16.80% ROA 1.78% Short Interest 21.35M Perf Year -16.81%
Cash/sh 8.79 P/C 7.22 EPS next 5Y 13.71% ROE 6.07% 52W Range 43.56 - 80.75 Perf YTD 41.41%
Dividend Est. 2.56 (4.03%) P/FCF 12.65 EPS past 5Y -6.37% ROI 3.06% 52W High -21.39% Beta 0.56
Dividend TTM 2.66 (4.19%) Quick Ratio 0.60 Sales past 5Y 7.79% Gross Margin 13.76% 52W Low 45.73% ATR (14) 2.20
Dividend Ex-Date Jan 23, 2025 Current Ratio 0.81 EPS Y/Y TTM -43.51% Oper. Margin 2.66% RSI (14) 66.18 Volatility 3.20% 3.23%
Employees 300000 Debt/Eq 1.10 Sales Y/Y TTM 4.02% Profit Margin 1.24% Recom 1.73 Target Price 71.39
Option/Short Yes / Yes LT Debt/Eq 1.00 EPS Q/Q -17.61% Payout 72.76% Rel Volume 1.04 Prev Close 65.09
Sales Surprise 0.64% EPS Surprise 30.25% Sales Q/Q 3.77% Earnings Feb 12 BMO Avg Volume 13.44M Price 63.48
SMA20 7.61% SMA50 20.79% SMA200 11.19% Trades
Volume 14,038,884 Change -2.47%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-13-25 Upgrade Leerink Partners
Market Perform → Outperform
$55 → $75
Feb-12-25 Upgrade Cantor Fitzgerald
Neutral → Overweight
Jan-30-25 Upgrade Edward Jones
Hold → Buy
Dec-03-24 Upgrade Deutsche Bank
Hold → Buy
$66
Nov-18-24 Upgrade Wells Fargo
Equal Weight → Overweight
$60 → $66
Oct-10-24 Upgrade Barclays
Equal Weight → Overweight
$63 → $82
Oct-04-24 Upgrade TD Cowen
Hold → Buy
$59 → $85
May-30-24 Initiated Robert W. Baird
Neutral
$61
May-07-24 Downgrade TD Cowen
Buy → Hold
$99 → $59
May-02-24 Downgrade UBS
Buy → Neutral
$85 → $60
May-01-24 Downgrade Leerink Partners
Outperform → Market Perform
$87 → $60
May-01-24 Downgrade Cantor Fitzgerald
Overweight → Neutral
Mar-06-24 Initiated Barclays
Equal Weight
$78
Feb-26-24 Initiated Leerink Partners
Outperform
$88
Dec-22-23 Initiated HSBC Securities
Buy
$94
Sep-19-23 Upgrade Evercore ISI
In-line → Outperform
$81 → $83
Sep-12-23 Upgrade Wolfe Research
Peer Perform → Outperform
$80
Aug-18-23 Downgrade Edward Jones
Buy → Hold
May-26-23 Initiated Piper Sandler
Overweight
$85
Apr-21-23 Initiated Cantor Fitzgerald
Overweight
$87
Show Previous Ratings
Feb-21-25 06:36PM
04:54PM
(The Wall Street Journal)
02:53PM
01:22PM
(The Wall Street Journal)
Feb-20-25 02:00PM
(Investor's Business Daily)
05:23PM
Loading…
Feb-19-25 05:23PM
05:17PM
(The Wall Street Journal)
04:55PM
04:00PM
05:28AM
Feb-18-25 09:00PM
(The Wall Street Journal)
04:51PM
04:48PM
12:15PM
04:24AM
04:21PM
Loading…
Feb-17-25 04:21PM
09:30AM
Feb-15-25 10:06AM
Feb-14-25 09:55AM
07:03AM
Feb-13-25 06:51PM
02:46PM
01:32PM
10:17AM
09:37AM
09:14AM
08:24AM
02:08AM
12:20AM
(Thomson Reuters StreetEvents)
12:04AM
04:59PM
Loading…
Feb-12-25 04:59PM
04:59PM
04:36PM
04:29PM
04:25PM
04:06PM
(Investor's Business Daily)
01:59PM
01:54PM
(Investor's Business Daily)
01:49PM
01:15PM
01:10PM
12:01PM
11:54AM
11:54AM
11:11AM
11:05AM
(Investor's Business Daily)
10:59AM
10:30AM
10:27AM
10:24AM
09:30AM
09:10AM
08:29AM
08:23AM
(Associated Press Finance)
08:23AM
07:48AM
07:40AM
07:04AM
06:57AM
06:55AM
06:40AM
06:37AM
06:37AM
(Associated Press Finance)
06:30AM
Feb-11-25 07:00PM
04:30PM
02:30PM
09:03AM
08:01AM
Feb-10-25 09:30AM
Feb-08-25 03:53PM
Feb-07-25 09:15AM
08:45AM
Feb-05-25 05:45PM
10:00AM
04:51AM
Feb-04-25 09:55AM
Feb-03-25 02:38PM
(The Wall Street Journal)
Feb-01-25 01:14PM
(The Wall Street Journal)
Jan-31-25 10:10AM
06:00AM
(The Wall Street Journal)
Jan-30-25 05:45PM
03:34PM
(The Wall Street Journal)
09:39AM
Jan-29-25 06:37PM
06:37PM
06:37PM
06:37PM
04:06PM
07:10AM
05:30AM
Jan-28-25 02:34PM
12:18PM
11:18AM
09:00AM
09:00AM
08:00AM
12:01AM
(The Wall Street Journal)
Jan-25-25 09:00PM
(The Wall Street Journal)
Jan-24-25 05:45PM
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Mahoney Michael F Director Feb 18 '25 Buy 66.70 30,000 2,001,000 39,356 Feb 19 12:35 PM LUDWIG EDWARD J Director May 02 '24 Buy 53.88 1,000 53,879 21,630 May 02 04:31 PM Mahoney Michael F Director May 02 '24 Buy 54.49 9,181 500,294 9,356 May 02 04:30 PM
Index S&P 500 P/E 34.35 EPS (ttm) 7.03 Insider Own 6.90% Shs Outstand 193.85M Perf Week -1.27%
Market Cap 46.82B Forward P/E 14.35 EPS next Y 16.82 Insider Trans -9.50% Shs Float 180.54M Perf Month -2.24%
Income 1.40B PEG 3.33 EPS next Q 4.06 Inst Own 91.24% Short Float 4.99% Perf Quarter -0.59%
Sales 303.19B P/S 0.15 EPS this Y 11.78% Inst Trans 0.05% Short Ratio 6.75 Perf Half Y 1.27%
Book/sh 1.17 P/B 206.55 EPS next Y 9.38% ROA 2.09% Short Interest 9.01M Perf Year 3.90%
Cash/sh 17.16 P/C 14.07 EPS next 5Y 10.33% ROE 245.32% 52W Range 214.77 - 262.26 Perf YTD 7.46%
Dividend Est. 1.96 (0.81%) P/FCF - EPS past 5Y 13.29% ROI 22.66% 52W High -7.94% Beta 0.50
Dividend TTM 2.12 (0.88%) Quick Ratio 0.54 Sales past 5Y 10.39% Gross Margin 2.89% 52W Low 12.41% ATR (14) 4.52
Dividend Ex-Date Feb 14, 2025 Current Ratio 0.92 EPS Y/Y TTM -23.54% Oper. Margin 1.00% RSI (14) 44.19 Volatility 1.80% 1.80%
Employees 46000 Debt/Eq 35.96 Sales Y/Y TTM 11.64% Profit Margin 0.46% Recom 1.78 Target Price 282.43
Option/Short Yes / Yes LT Debt/Eq 26.20 EPS Q/Q -16.00% Payout 27.07% Rel Volume 0.80 Prev Close 243.46
Sales Surprise 4.06% EPS Surprise 6.50% Sales Q/Q 12.78% Earnings Feb 05 BMO Avg Volume 1.33M Price 241.43
SMA20 -2.96% SMA50 0.81% SMA200 3.04% Trades
Volume 1,060,825 Change -0.83%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-04-24 Resumed Mizuho
Outperform
$280
Sep-18-24 Downgrade BofA Securities
Buy → Neutral
$275 → $245
Feb-26-24 Initiated Leerink Partners
Outperform
$261
Jan-03-24 Initiated Barclays
Overweight
$242
Dec-14-23 Initiated Wells Fargo
Equal Weight
$213
Mar-31-23 Initiated Citigroup
Buy
$185
Jan-31-23 Resumed Evercore ISI
Outperform
$185
Oct-11-22 Upgrade BofA Securities
Neutral → Buy
$160 → $169
Aug-22-22 Resumed Morgan Stanley
Equal-Weight
Jul-11-22 Downgrade Evercore ISI
Outperform → In-line
$150
Jun-07-22 Upgrade Deutsche Bank
Hold → Buy
$167 → $178
May-26-22 Upgrade Barclays
Equal Weight → Overweight
Apr-12-22 Downgrade Morgan Stanley
Overweight → Equal-Weight
$178
Apr-01-22 Resumed Credit Suisse
Outperform
$180
Feb-04-21 Upgrade Evercore ISI
In-line → Outperform
Jan-06-21 Upgrade BofA Securities
Underperform → Neutral
Jun-15-20 Upgrade Morgan Stanley
Equal-Weight → Overweight
$112
Apr-23-20 Resumed Credit Suisse
Outperform
$105
Apr-01-20 Upgrade JP Morgan
Neutral → Overweight
$93 → $106
Feb-07-20 Upgrade Robert W. Baird
Neutral → Outperform
$112
Show Previous Ratings
Feb-21-25 09:45AM
Feb-20-25 09:40AM
Feb-11-25 05:30AM
(The Wall Street Journal)
Feb-06-25 08:37PM
08:30PM
01:33PM
Loading…
Feb-05-25 01:33PM
06:30AM
Feb-03-25 09:40AM
Jan-30-25 02:46PM
Jan-27-25 12:10PM
07:30AM
Jan-10-25 07:36AM
Jan-09-25 09:50AM
Jan-08-25 07:30AM
Jan-02-25 04:15PM
12:00PM
Loading…
Jan-01-25 12:00PM
09:45AM
Dec-31-24 09:40AM
08:11AM
Dec-16-24 09:45AM
Dec-14-24 06:35AM
Dec-09-24 04:15PM
Dec-02-24 10:49PM
02:22PM
Nov-25-24 09:40AM
Nov-13-24 06:27PM
(Investor's Business Daily)
09:45AM
Nov-11-24 09:50AM
Nov-08-24 03:37PM
(Investor's Business Daily)
Nov-07-24 07:01AM
06:36AM
Loading…
06:36AM
Nov-06-24 03:07PM
09:40AM
06:35AM
06:30AM
Nov-04-24 08:30AM
Oct-21-24 09:40AM
Oct-15-24 12:10PM
Oct-11-24 09:45AM
Oct-01-24 07:30AM
Sep-27-24 07:00AM
(The Wall Street Journal)
Sep-18-24 07:10PM
12:37PM
Aug-30-24 09:40AM
Aug-22-24 09:45AM
Aug-15-24 07:30AM
Aug-14-24 09:40AM
Aug-05-24 05:48PM
Aug-02-24 12:51PM
12:00PM
11:51AM
Aug-01-24 06:17PM
06:08PM
Jul-31-24 04:44PM
06:30AM
Jul-30-24 09:50AM
Jul-29-24 09:40AM
Jul-25-24 08:30AM
Jul-12-24 09:40AM
Jul-11-24 12:10PM
07:00AM
Jul-08-24 08:35AM
Jul-05-24 04:15PM
Jul-03-24 03:50PM
Jun-28-24 08:03AM
07:52AM
Jun-26-24 07:44AM
Jun-25-24 07:30AM
Jun-24-24 08:28AM
Jun-17-24 11:34AM
Jun-10-24 09:40AM
Jun-02-24 04:00PM
May-31-24 11:31AM
May-27-24 07:42AM
May-24-24 02:00PM
May-23-24 09:40AM
May-22-24 05:44PM
05:38PM
May-15-24 05:17PM
May-02-24 01:00PM
May-01-24 10:00PM
04:24PM
08:44AM
07:40AM
06:30AM
Apr-26-24 09:15AM
07:29AM
Apr-15-24 09:40AM
07:48AM
Apr-12-24 09:45AM
Apr-05-24 08:30AM
Apr-04-24 09:15AM
Apr-01-24 12:38PM
Mar-29-24 09:40AM
04:27AM
Mar-28-24 10:03AM
Mar-27-24 09:45AM
07:19AM
Mar-19-24 09:48AM
09:15AM
Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. The U.S. Healthcare Solutions segment is involved in the offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers. The International Healthcare Solutions segment includes businesses that focus on international pharmaceutical wholesale and related service operations, and global commercialization services. The company was founded by Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Battaglia Silvana Officer Feb 21 '25 Proposed Sale 242.24 5,000 1,211,200 Feb 21 12:18 PM Walgreens Boots Alliance, Inc. 10% Owner Feb 06 '25 Sale 244.51 1,286,376 314,531,796 12,570,000 Feb 10 07:35 PM Walgreens Boots Alliance Holdi Affiliate Feb 06 '25 Proposed Sale 246.13 1,081,885 266,284,355 Feb 06 07:55 PM Battaglia Silvana Executive Vice President Dec 20 '24 Sale 228.72 1,678 383,792 20,329 Dec 23 03:47 PM Battaglia Silvana Officer Dec 20 '24 Proposed Sale 228.72 1,678 383,792 Dec 20 01:48 PM Krikorian Lazarus SVP & Chief Accounting Officer Dec 03 '24 Sale 250.41 1,816 454,754 21,988 Dec 04 04:22 PM Krikorian Lazarus Officer Dec 03 '24 Proposed Sale 250.42 1,816 454,754 Dec 03 11:13 AM Cleary James F Chief Financial Officer Nov 27 '24 Option Exercise 89.58 33,877 3,034,702 171,508 Dec 02 04:01 PM COLLIS STEVEN H Executive Chairman Nov 25 '24 Sale 243.97 50,000 12,198,750 326,557 Nov 26 04:31 PM COLLIS STEVEN H Director Nov 25 '24 Proposed Sale 243.98 50,000 12,198,760 Nov 25 04:04 PM COLLIS STEVEN H Executive Chairman Nov 19 '24 Option Exercise 89.58 21,509 1,926,776 328,261 Nov 21 04:49 PM COLLIS STEVEN H Executive Chairman Nov 19 '24 Sale 242.16 21,509 5,208,619 306,752 Nov 21 04:49 PM COLLIS STEVEN H Director Nov 19 '24 Proposed Sale 242.16 21,509 5,208,619 Nov 19 10:00 AM COLLIS STEVEN H Executive Chairman Oct 22 '24 Option Exercise 89.58 21,509 1,926,776 306,597 Oct 23 04:06 PM COLLIS STEVEN H Executive Chairman Oct 22 '24 Sale 235.80 21,509 5,071,822 285,088 Oct 23 04:06 PM COLLIS STEVEN H Officer Oct 22 '24 Proposed Sale 235.80 21,509 5,071,822 Oct 22 10:43 AM COLLIS STEVEN H Chairman, President & CEO Sep 17 '24 Option Exercise 89.58 21,509 1,926,776 306,597 Sep 18 04:37 PM COLLIS STEVEN H Chairman, President & CEO Sep 17 '24 Sale 241.01 21,509 5,183,884 285,088 Sep 18 04:37 PM Lon Greenberg Other: Board Sep 17 '24 Proposed Sale 239.88 4,000 959,520 Sep 17 05:27 PM COLLIS STEVEN H Officer Sep 17 '24 Proposed Sale 241.01 21,509 5,183,884 Sep 17 09:36 AM COLLIS STEVEN H Chairman, President & CEO Aug 20 '24 Option Exercise 89.58 10,754 963,343 295,842 Aug 21 04:08 PM COLLIS STEVEN H Chairman, President & CEO Aug 20 '24 Sale 239.13 10,754 2,571,604 285,088 Aug 21 04:08 PM COLLIS STEVEN H Officer Aug 20 '24 Proposed Sale 239.13 10,754 2,571,604 Aug 20 10:47 AM Battaglia Silvana Executive Vice President Aug 06 '24 Sale 242.69 1,473 357,482 10,948 Aug 07 04:09 PM Battaglia Silvana Officer Aug 06 '24 Proposed Sale 242.69 1,473 357,483 Aug 06 02:08 PM Walgreens Boots Alliance, Inc. 10% Owner Aug 01 '24 Sale 240.56 4,438,171 1,067,646,416 19,980,000 Aug 05 06:44 PM Walgreens Boots Alliance Holdi Affiliate Aug 01 '24 Proposed Sale 244.46 3,398,929 830,902,183 Aug 01 08:56 PM COLLIS STEVEN H Chairman, President & CEO Jul 16 '24 Option Exercise 89.58 10,755 963,433 295,843 Jul 17 04:09 PM COLLIS STEVEN H Chairman, President & CEO Jul 16 '24 Sale 222.12 10,755 2,388,901 285,088 Jul 17 04:09 PM Donato Leslie E EVP & Chief Strategy Officer Jul 01 '24 Option Exercise 0.00 1,432 0 9,991 Jul 02 04:08 PM COLLIS STEVEN H Chairman, President & CEO Jun 18 '24 Option Exercise 89.58 10,754 963,343 295,842 Jun 20 04:16 PM COLLIS STEVEN H Chairman, President & CEO Jun 18 '24 Sale 235.76 10,754 2,535,363 285,088 Jun 20 04:16 PM Clark Gina Executive Vice President May 31 '24 Sale 223.86 1,874 419,506 13,284 Jun 03 04:05 PM Clark Gina Executive Vice President May 29 '24 Option Exercise 86.09 27,093 2,332,436 42,251 May 31 04:00 PM Clark Gina Executive Vice President May 29 '24 Sale 216.07 27,093 5,853,985 15,158 May 31 04:00 PM Clark Gina Executive Vice President Mar 18 '24 Sale 238.12 9,644 2,296,429 15,158 May 31 04:00 PM DURCAN DERMOT MARK Director May 24 '24 Buy 218.58 500 109,290 21,876 May 29 04:02 PM Walgreens Boots Alliance, Inc. 10% Owner May 22 '24 Sale 215.12 1,859,390 400,000,158 24,418,171 May 24 04:05 PM COLLIS STEVEN H Chairman, President & CEO May 21 '24 Option Exercise 89.58 10,755 963,433 295,843 May 22 04:08 PM COLLIS STEVEN H Chairman, President & CEO May 21 '24 Sale 221.30 10,755 2,380,082 285,088 May 22 04:08 PM Mauch Robert P. Executive Vice President & COO Apr 15 '24 Option Exercise 89.58 33,877 3,034,702 81,976 Apr 17 04:24 PM Mauch Robert P. Executive Vice President & COO Apr 15 '24 Sale 235.09 57,564 13,532,721 24,412 Apr 17 04:24 PM COLLIS STEVEN H Chairman, President & CEO Apr 16 '24 Option Exercise 89.58 10,754 963,343 295,842 Apr 17 04:23 PM COLLIS STEVEN H Chairman, President & CEO Apr 16 '24 Sale 237.48 10,754 2,553,860 285,088 Apr 17 04:23 PM COLLIS STEVEN H Chairman, President & CEO Mar 19 '24 Option Exercise 89.58 10,755 963,433 295,843 Mar 21 04:05 PM COLLIS STEVEN H Chairman, President & CEO Mar 19 '24 Sale 240.21 10,755 2,583,459 285,088 Mar 21 04:05 PM Campbell Elizabeth S Executive Vice President Mar 18 '24 Sale 238.12 6,977 1,661,363 8,246 Mar 20 04:23 PM
Index - P/E 408.41 EPS (ttm) 0.01 Insider Own 17.61% Shs Outstand 20.66M Perf Week -2.24%
Market Cap 90.27M Forward P/E - EPS next Y -0.07 Insider Trans 7.21% Shs Float 17.02M Perf Month -12.60%
Income 0.36M PEG - EPS next Q -0.04 Inst Own 43.52% Short Float 7.56% Perf Quarter -2.24%
Sales 247.01M P/S 0.37 EPS this Y 155.41% Inst Trans -7.53% Short Ratio 4.35 Perf Half Y 38.29%
Book/sh 4.66 P/B 0.94 EPS next Y -136.59% ROA 0.22% Short Interest 1.29M Perf Year -15.80%
Cash/sh 2.43 P/C 1.80 EPS next 5Y - ROE 0.36% 52W Range 2.90 - 6.85 Perf YTD -9.34%
Dividend Est. 0.01 (0.23%) P/FCF 104.97 EPS past 5Y - ROI 0.37% 52W High -36.20% Beta 0.78
Dividend TTM - Quick Ratio 1.18 Sales past 5Y 0.18% Gross Margin 24.90% 52W Low 50.69% ATR (14) 0.31
Dividend Ex-Date Aug 11, 2023 Current Ratio 1.43 EPS Y/Y TTM 104.54% Oper. Margin 0.23% RSI (14) 41.90 Volatility 4.41% 6.33%
Employees 287 Debt/Eq 0.01 Sales Y/Y TTM -10.82% Profit Margin 0.14% Recom 4.00 Target Price 3.75
Option/Short Yes / Yes LT Debt/Eq 0.01 EPS Q/Q 65.42% Payout - Rel Volume 0.89 Prev Close 4.41
Sales Surprise -11.69% EPS Surprise -700.00% Sales Q/Q -18.88% Earnings Feb 10 AMC Avg Volume 295.81K Price 4.37
SMA20 -8.40% SMA50 -13.04% SMA200 2.42% Trades
Volume 262,283 Change -0.91%
Date
Action
Analyst
Rating Change
Price Target Change
May-25-23 Initiated Lake Street
Buy
$20
Jan-20-22 Upgrade Sidoti
Neutral → Buy
$32
Nov-18-21 Initiated Morgan Stanley
Underweight
$25
Oct-01-21 Initiated Jefferies
Hold
$28
Aug-05-21 Resumed Credit Suisse
Underperform
$22
Jun-03-21 Downgrade Sidoti
Buy → Neutral
$39
Mar-05-21 Upgrade Sidoti
Neutral → Buy
Jan-27-21 Downgrade Sidoti
Buy → Neutral
Aug-19-20 Upgrade Sidoti
Neutral → Buy
$37 → $41
Apr-09-20 Downgrade Sidoti
Buy → Neutral
Mar-12-20 Upgrade Sidoti
Neutral → Buy
$31
Feb-24-20 Downgrade Sidoti
Buy → Neutral
Aug-16-19 Upgrade Craig Hallum
Sell → Hold
Aug-16-19 Downgrade Craig Hallum
Buy → Hold
Jun-15-18 Initiated CL King
Neutral
Aug-24-17 Upgrade Sidoti
Neutral → Buy
Jul-24-17 Upgrade Northcoast
Neutral → Buy
May-09-16 Upgrade Craig Hallum
Sell → Hold
Feb-04-16 Initiated Credit Suisse
Underperform
Jul-19-10 Reiterated JMP Securities
Mkt Outperform
$23 → $21
Show Previous Ratings
Feb-11-25 07:05AM
(Thomson Reuters StreetEvents) -14.04%
02:05AM
Feb-10-25 04:16PM
(Associated Press Finance)
04:05PM
Feb-07-25 07:09AM
04:05PM
Loading…
Jan-30-25 04:05PM
Jan-07-25 08:00AM
Dec-23-24 09:50AM
Dec-05-24 09:50AM
Dec-03-24 08:30AM
Nov-30-24 07:19PM
Nov-14-24 10:00AM
09:50AM
Nov-07-24 04:05PM
02:20AM
04:48PM
Loading…
Nov-06-24 04:48PM
(Associated Press Finance)
04:05PM
Nov-05-24 08:08AM
Oct-24-24 02:46PM
08:00AM
Oct-09-24 09:50AM
Sep-27-24 04:17PM
Sep-23-24 09:50AM
Sep-12-24 08:00AM
Aug-21-24 08:30AM
Aug-07-24 12:45PM
(Thomson Reuters StreetEvents) -14.36%
Aug-06-24 05:41PM
(Associated Press Finance)
04:05PM
Aug-05-24 04:05PM
Jul-23-24 08:00AM
01:36PM
Loading…
Jun-27-24 01:36PM
01:36PM
Jun-24-24 08:00AM
Jun-16-24 07:00AM
Jun-12-24 08:02AM
03:52AM
Jun-11-24 08:53PM
04:25PM
(Associated Press Finance)
04:05PM
Jun-03-24 08:00AM
May-28-24 08:00AM
May-22-24 04:05PM
May-20-24 08:00AM
Apr-30-24 08:34AM
Apr-29-24 10:25AM
08:15AM
Apr-15-24 12:52PM
08:26AM
(Associated Press Finance)
08:16AM
Apr-04-24 01:45PM
Mar-18-24 03:44AM
Mar-13-24 08:17AM
Feb-28-24 06:00PM
Feb-22-24 04:21AM
Feb-16-24 08:30AM
Feb-15-24 01:34PM
08:30AM
Feb-14-24 01:47AM
Feb-09-24 09:26AM
06:05AM
(Thomson Reuters StreetEvents)
Feb-08-24 04:56PM
04:01PM
Jan-29-24 08:30AM
Jan-08-24 05:46PM
Dec-19-23 06:36PM
Dec-16-23 07:00AM
Dec-08-23 04:35PM
Dec-07-23 02:56PM
Nov-27-23 12:26PM
Nov-13-23 10:40AM
Nov-06-23 04:50PM
Oct-31-23 08:28AM
08:10AM
05:26AM
(Thomson Reuters StreetEvents)
Oct-30-23 05:56PM
04:43PM
(Associated Press Finance)
04:01PM
Oct-19-23 08:30AM
Oct-12-23 06:20PM
Oct-11-23 01:18PM
Sep-19-23 09:00AM
Sep-07-23 04:01PM
07:30AM
Aug-06-23 08:05AM
Aug-04-23 06:04AM
Aug-01-23 07:09AM
(Thomson Reuters StreetEvents) -5.87%
Jul-31-23 04:21PM
04:01PM
Jul-19-23 06:05AM
Jul-18-23 09:09AM
Jul-17-23 08:30AM
Jul-12-23 06:51AM
Jul-07-23 08:40AM
Jul-04-23 10:24AM
Jul-03-23 09:49PM
Jun-23-23 09:07AM
Jun-02-23 06:46PM
Jun-01-23 08:30AM
May-30-23 06:45AM
May-23-23 06:48AM
(Thomson Reuters StreetEvents)
PetMed Express, Inc. provides markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. Its non-prescription medications include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. The prescription medications include heartworm preventatives, arthritis, thyroid, diabetes and pain medications, heart/blood pressure, and other specialty medications, and generic substitutes. The company was founded in January 1996 and is headquartered in Delray Beach, FL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
NINA CAPITAL HOLDINGS INC. 10% Owner Feb 03 '25 Buy 4.82 25,000 120,500 2,250,000 Feb 04 06:01 PM NINA CAPITAL HOLDINGS INC. 10% Owner Jan 24 '25 Buy 4.95 25,000 123,675 2,200,000 Jan 28 04:15 PM NINA CAPITAL HOLDINGS INC. 10% Owner Jan 27 '25 Buy 4.63 25,000 115,875 2,225,000 Jan 28 04:15 PM NINA CAPITAL HOLDINGS INC. 10% Owner Jan 07 '25 Buy 4.97 25,000 124,375 2,175,000 Jan 10 04:05 PM NINA CAPITAL HOLDINGS INC. 10% Owner Dec 16 '24 Buy 5.66 32,000 180,960 2,150,000 Dec 18 04:15 PM NINA CAPITAL HOLDINGS INC. 10% Owner Dec 06 '24 Buy 5.55 40,000 222,000 2,118,000 Dec 10 04:15 PM Campbell Leslie C.G. Director Dec 05 '24 Buy 5.44 15,000 81,650 30,000 Dec 06 09:06 PM Campbell Leslie C.G. Director Dec 05 '24 Buy 5.42 15,000 81,354 85,000 Dec 06 09:06 PM Campbell Leslie C.G. Director Dec 04 '24 Buy 5.40 15,000 81,000 15,000 Dec 06 09:06 PM Campbell Leslie C.G. Director Dec 04 '24 Buy 5.38 15,000 80,632 70,000 Dec 06 09:06 PM NINA CAPITAL HOLDINGS INC. 10% Owner Sep 09 '24 Buy 3.34 12,500 41,750 2,078,000 Oct 18 08:18 PM Smith Jacqueline Paula Vice President of People Aug 15 '24 Sale 3.19 601 1,917 20,099 Aug 19 05:05 PM
Index RUT P/E - EPS (ttm) - Insider Own 85.57% Shs Outstand 9.20M Perf Week -3.26%
Market Cap 1.24B Forward P/E - EPS next Y - Insider Trans 0.11% Shs Float 9.13M Perf Month -7.03%
Income - PEG - EPS next Q 0.20 Inst Own 15.42% Short Float 8.86% Perf Quarter -8.46%
Sales - P/S - EPS this Y - Inst Trans 11.58% Short Ratio 5.43 Perf Half Y -
Book/sh 2.02 P/B 9.71 EPS next Y - ROA - Short Interest 0.81M Perf Year -
Cash/sh 0.59 P/C 33.30 EPS next 5Y - ROE - 52W Range 14.16 - 25.74 Perf YTD -3.36%
Dividend Est. - P/FCF - EPS past 5Y - ROI - 52W High -23.92% Beta -
Dividend TTM - Quick Ratio 0.85 Sales past 5Y 14.93% Gross Margin - 52W Low 38.28% ATR (14) 1.10
Dividend Ex-Date - Current Ratio 1.14 EPS Y/Y TTM - Oper. Margin - RSI (14) 40.72 Volatility 5.21% 4.94%
Employees - Debt/Eq 0.59 Sales Y/Y TTM - Profit Margin - Recom 1.33 Target Price 24.33
Option/Short No / Yes LT Debt/Eq 0.41 EPS Q/Q -1914.00% Payout - Rel Volume 0.29 Prev Close 20.11
Sales Surprise 3.72% EPS Surprise 43.15% Sales Q/Q 40.31% Earnings Nov 13 BMO Avg Volume 148.99K Price 19.58
SMA20 -8.01% SMA50 -8.78% SMA200 -5.11% Trades
Volume 43,787 Change -2.64%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-21-24 Initiated Truist
Buy
$22
Oct-21-24 Initiated Raymond James
Outperform
$21
Feb-17-25 04:05PM
Dec-17-24 09:00AM
Nov-12-24 04:41PM
(Associated Press Finance)
-10.73%
04:05PM
Oct-31-24 08:00AM
08:00AM
Loading…
Oct-30-24 08:00AM
Oct-21-24 02:54PM
Oct-08-24 09:02AM
Sep-26-24 10:50AM
Sep-25-24 09:45PM
09:10PM
Guardian Pharmacy Services, Inc. engages in the provision of client service and resident care to long-term care communities. It offers assisted living and skilled nursing, group homes, behavioral health and organizations that serve individuals with intellectual and developmental disabilities. The company was founded by Fred Burke, David Morris, and Kendall Forbes on July 21, 2003 and is headquartered in Atlanta, GA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
COSLER STEVEN D Director Nov 19 '24 Buy 21.22 7,000 148,540 17,713 Nov 20 04:05 PM Salentine Thomas J Jr Director Sep 27 '24 Buy 14.00 35,714 499,996 35,714 Oct 01 05:48 PM Patchett Mary Sue Director Sep 27 '24 Buy 14.00 3,571 49,994 3,571 Oct 01 05:46 PM LEWIS RANDALL J Director Sep 27 '24 Buy 14.00 3,571 49,994 3,571 Oct 01 05:43 PM COSLER STEVEN D Director Sep 27 '24 Buy 14.00 7,142 99,988 7,142 Oct 01 05:43 PM
Index S&P 500 P/E - EPS (ttm) -10.24 Insider Own 17.93% Shs Outstand 863.49M Perf Week 4.21%
Market Cap 8.78B Forward P/E 6.80 EPS next Y 1.49 Insider Trans 0.00% Shs Float 709.24M Perf Month -12.56%
Income -8834.00M PEG - EPS next Q 0.53 Inst Own 63.18% Short Float 8.96% Perf Quarter 17.32%
Sales 150.41B P/S 0.06 EPS this Y -43.91% Inst Trans 1.85% Short Ratio 2.48 Perf Half Y -5.31%
Book/sh 11.51 P/B 0.88 EPS next Y -7.48% ROA -10.02% Short Interest 63.51M Perf Year -54.46%
Cash/sh 1.38 P/C 7.37 EPS next 5Y -16.60% ROE -60.05% 52W Range 8.08 - 22.05 Perf YTD 8.90%
Dividend Est. 1.05 (10.34% ) P/FCF - EPS past 5Y - ROI -23.36% 52W High -53.92% Beta 0.61
Dividend TTM 0.75 (7.38% ) Quick Ratio 0.30 Sales past 5Y 1.77% Gross Margin 16.00% 52W Low 25.74% ATR (14) 0.62
Dividend Ex-Date Nov 18, 2024 Current Ratio 0.64 EPS Y/Y TTM -1637.59% Oper. Margin 1.04% RSI (14) 47.84 Volatility 6.77% 5.55%
Employees 312000 Debt/Eq 3.09 Sales Y/Y TTM 5.62% Profit Margin -5.87% Recom 2.80 Target Price 11.14
Option/Short Yes / Yes LT Debt/Eq 2.80 EPS Q/Q -295.36% Payout - Rel Volume 0.95 Prev Close 10.51
Sales Surprise 5.50% EPS Surprise 34.78% Sales Q/Q 7.50% Earnings Jan 10 BMO Avg Volume 25.64M Price 10.16
SMA20 -2.21% SMA50 -1.90% SMA200 -8.92% Trades
Volume 24,323,850 Change -3.33%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-26-24 Initiated Leerink Partners
Market Perform
$23
Feb-20-24 Downgrade HSBC Securities
Hold → Reduce
Jan-03-24 Initiated Barclays
Underweight
$21
Dec-22-23 Initiated HSBC Securities
Hold
$27
Oct-23-23 Upgrade JP Morgan
Neutral → Overweight
$27 → $30
Jul-03-23 Reiterated Morgan Stanley
Underweight
$37 → $27
Jun-28-23 Downgrade Deutsche Bank
Buy → Hold
$46 → $34
Feb-23-23 Initiated Loop Capital
Buy
$45
Nov-23-22 Resumed Morgan Stanley
Underweight
$39
Nov-22-22 Upgrade Cowen
Market Perform → Outperform
$43 → $54
Nov-18-22 Upgrade JP Morgan
Neutral → Overweight
$42
Nov-11-22 Upgrade Deutsche Bank
Hold → Buy
Apr-01-22 Downgrade Robert W. Baird
Outperform → Neutral
$70 → $51
Dec-16-21 Downgrade Morgan Stanley
Equal-Weight → Underweight
$56 → $49
Mar-25-21 Reiterated Deutsche Bank
Hold
$49 → $55
Jan-11-21 Upgrade Robert W. Baird
Neutral → Outperform
$55
Jan-11-21 Upgrade Guggenheim
Neutral → Buy
$55
Jan-08-21 Resumed Credit Suisse
Neutral
$42
Apr-06-20 Upgrade UBS
Sell → Neutral
$49 → $44
Apr-03-20 Upgrade Deutsche Bank
Sell → Hold
$51 → $43
Show Previous Ratings
Feb-20-25 03:48PM
09:00AM
Feb-19-25 12:24PM
08:14AM
Feb-18-25 07:51PM
(Morningstar Research) +14.02%
04:15PM
Loading…
04:15PM
02:53PM
02:27PM
01:19PM
12:44PM
12:13PM
11:51AM
11:23AM
Feb-14-25 05:45PM
07:00AM
05:45AM
Loading…
05:45AM
Feb-13-25 05:16PM
02:53PM
01:32PM
12:06AM
Feb-12-25 04:18AM
Feb-11-25 07:01PM
(Morningstar Research) -6.12%
05:45AM
Feb-09-25 09:00PM
(The Wall Street Journal)
Feb-07-25 05:45PM
08:47AM
08:45AM
Feb-06-25 10:25PM
08:30PM
02:09AM
01:50PM
Loading…
Feb-05-25 01:50PM
(Associated Press Finance)
10:44AM
09:40AM
Feb-04-25 05:50PM
08:05AM
05:45AM
Feb-01-25 09:19AM
Jan-31-25 05:50PM
(Barrons.com) -10.30%
-5.06%
12:59PM
12:52PM
12:49PM
12:02PM
11:26AM
11:10AM
10:54AM
10:10AM
10:06AM
10:00AM
09:50AM
09:33AM
08:25AM
(Associated Press Finance)
07:22AM
Jan-30-25 05:37PM
(The Wall Street Journal)
05:10PM
04:55PM
12:34PM
09:15AM
Jan-29-25 11:47AM
08:01AM
Jan-27-25 06:54PM
03:50PM
11:42AM
11:04AM
Jan-24-25 07:45AM
Jan-22-25 04:56PM
11:48AM
10:15AM
05:30AM
Jan-21-25 07:40PM
05:13PM
04:25PM
04:02PM
(Investor's Business Daily)
01:15PM
12:33PM
12:13PM
11:57AM
11:52AM
11:24AM
11:23AM
11:01AM
04:30AM
Jan-20-25 10:45AM
04:46AM
Jan-18-25 03:56PM
08:39AM
Jan-17-25 08:00PM
(Associated Press Finance)
-9.19%
05:14PM
(The Wall Street Journal)
05:11PM
04:02PM
02:47PM
06:41AM
05:36AM
Jan-16-25 03:49PM
Jan-15-25 10:48AM
Jan-14-25 05:03PM
Jan-13-25 11:25AM
09:59AM
09:05AM
05:28AM
Jan-12-25 05:17PM
Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Walgreens Boots Alliance, Inc. Former 10% owner Feb 18 '25 Sale 21.16 12,000,000 253,920,000 11,239,996 Feb 20 04:30 PM Walgreens Boots Alliance, Inc. 10% Owner Feb 06 '25 Sale 244.51 1,286,376 314,531,796 12,570,000 Feb 10 07:35 PM Walgreens Boots Alliance Holdi Affiliate Feb 06 '25 Proposed Sale 246.13 1,081,885 266,284,355 Feb 06 07:55 PM Walgreens Boots Alliance, Inc. 10% Owner Sep 11 '24 Sale 11.13 11,619,998 129,330,578 23,239,996 Sep 13 07:04 PM Walgreens Boots Alliance, Inc. 10% Owner Aug 01 '24 Sale 240.56 4,438,171 1,067,646,416 19,980,000 Aug 05 06:44 PM Walgreens Boots Alliance Holdi Affiliate Aug 01 '24 Proposed Sale 244.46 3,398,929 830,902,183 Aug 01 08:56 PM Walgreens Boots Alliance, Inc. 10% Owner May 22 '24 Sale 215.12 1,859,390 400,000,158 24,418,171 May 24 04:05 PM Bhandari Inderpal S Director Apr 11 '24 Buy 18.05 3,000 54,150 3,000 Apr 15 05:45 PM Mahajan Manmohan EVP and Global CFO Apr 02 '24 Buy 19.38 6,000 116,280 166,969 Apr 02 06:40 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
